The origin is clinically significant: the gastric lining regenerates continuously despite exposure to acid and mechanical stress, and the peptide responsible for that regeneration turned out to be stable enough to isolate and study
Take-up rates for medications can vary widely depending on several factors, from the type of medication and potential side effects to patient demographics and treatment costs
However, these drugs appear to be having a wider impact than the physical state and are reshaping culture and society
Tirzepatide (Mounjaro, Zepbound) tends to produce greater weight loss than semaglutide (Ozempic, Wegovy), which may mean more aggressive caloric restriction and potentially larger nutritional gaps
Important conclusions drawn from recent meta-analyses involving over 300,000 patients report that while the retained gastric contents are significantly increased (fivefold to tenfold increase
These drugs work by slowing down how quickly the stomach empties and reducing hunger signals in the brain, particularly in the hypothalamus
